AnilTulpuleMD

PubMed

• The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, m...
  Park, S. I.,Horwitz, S. M.,Foss, F. M.,Pinter-Brown, L. C.,Carson, K. R.,Rosen, S. T.,Pro, B.,Hsi, E. D.,Federico, M.,Gisselbrecht, C.,Schwartz, M.,Bellm, L. A.,Acosta...> ;Cancer. 2019 Jan 30
• Cardiac birth defects in a twin infant born to a woman with chronic myeloid leukemia on dasatinib.
  Hermel, D. J.,Chiu, V.,Hermel, M. H.,Tulpule, A.,Akhtari, M.> ;J Oncol Pharm Pract. 2017 Dec 07
• A prospective cohort study of patients with peripheral T-cell lymphoma in the United States.
  Horwitz SM, Pinter-Brown LC, Rosen ST, Pro B, Hsi ED, Federico M, Gisselbrecht C, Schwartz M, Bellm LA, Acosta MA, Shustov AR, Advani RH, Feldman TA, Lechowicz MJ, Smi...> ;Cancer. 2016-12-02
• p53 Expression Is a Strong Marker of Inferior Survival in De Novo Diffuse Large B-Cell Lymphoma and May Have Enhanced Negative Effect With MYC Coexpression: A Single I...
  Xie, Y.,Bulbul, M. A.,Ji, L.,Inouye, C. M.,Groshen, S. G.,Tulpule, A.,O'Malley, D. P.,Wang, E.,Siddiqi, I. N.> ;Am. J. Clin. Pathol.. 2014 Mar 13
• Pegylated Liposomal Doxorubicin, Rituximab, Cyclophosphamide, Vincristine, and Prednisone in AIDS-Related Lymphoma: AIDS Malignancy Consortium Study 047
  Alexandra M Levine, Erin G Reid, Ronald Mitsuyasu, Anil Tulpule, Jeannette Y Lee, Wayne Tam, Ethel Cesarman, Bruce J Dezube, Ariela Noy> ;Journal of Clinical Oncology. 2013 Jan 1
• Improving the therapeutic index of anthracycline chemotherapy: focus on liposomal doxorubicin (Myocet).
  Leonard RCF, Williams S, Tulpule A, Levine AM, Oliveros S> ;Breast. 2009-08-01
• Phase II trial of pegylated liposomal doxorubicin (PLD), rituxan, cyclophosphamide, vincristine, and prednisone in aggressive B-cell non-Hodgkin's lymphoma.
  Gu H, Tulpule A, Berman N, Duran C, Groshen SG, Buchanan L, Boswell W, Nathwani B, Levine AM> ;J. Clin. Oncol.. 2008-05-20
• A phase I/II trial of pixantrone (BBR2778), methylprednisolone, cisplatin, and cytosine arabinoside (PSHAP) in relapsed/refractory aggressive non-Hodgkin's lymphoma.
  Lim S, Fayad L, Tulpule A, Modiano M, Cabanillas F, Laffranchi B, Allievi C, Bernareggi A, Levine AM> ;Leuk. Lymphoma. 2007-02-01
• 20 citations
  Phase I/II Trial of Nonpegylated Liposomal Doxorubicin, Cyclophosphamide, Vincristine, and Prednisone in the Treatment of Newly Diagnosed Aggressive Non-Hodgkin's Lymp...
  Anil Tulpule, Byron M. Espina, Nancy Berman, Laura H. Buchanan, D. Lynne Smith, Andy Sherrod, Dharshika Dharmapala, Conway Gee, William D. Boswell, Bharat N. Nathwani,...> ;Clinical Lymphoma & Myeloma. 2006 Jul 1
• A phase II, multicenter study of bendamustine HCl plus rituximab in relapsed indolent B-cell and mantle-cell non-Hodgkin's lymphoma (NHL).
  Williams ME, Cohen P, Tulpule A, Van der Jagt RH, Herst JA, Bessudo A, Lemieux B, Schwartzberg LS, Oliver JW, Robinson KS> ;J. Clin. Oncol.. 2006-06-20
• 7 citations
  Multidrug resistance in AIDS-related lymphoma.
  Anil Tulpule> ;Current Opinion in Oncology. 2005 Sep 1
• Prognostic factors in HIV-related diffuse large cell lymphoma (HIV-DLCL) in the pre and post-HAART (HT) era.
  Lim ST, Karim R, Tulpule A, Nathwani BN, Levine AM> ;J. Clin. Oncol.. 2005-06-01
• A phase II trial of pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone (DR-COP) in aggressive B-cell non-Hodgkin's lymphoma.
  Tulpule A, Duran CA, Smith DL, Berman NE, Buchanan L, Gorospe G, Boswell W, Nathwani B, Levine AM> ;J. Clin. Oncol.. 2005-06-01
• The novel alkylator bendamustine HCl is active in both rituximab-refractory and rituximab-sensitive relapsed indolent NHL with acceptable toxicity.
  Cohen P, Cheson B, Friedberg J, Robinson KS, Foran J, Fayad L, Tulpule A, Bessudo A, van der Jagt R, Suster MS, Multani PS> ;J. Clin. Oncol.. 2005-06-01
• Results of a pilot trial of fludarabine, mitoxantrone and rituximab in mantle cell lymphoma.
  Mohrbacher A, Khan AU, Tulpule A, Espina BM, Berman N, Mark L, Douer D, Feinstein DI, Levine A> ;J. Clin. Oncol.. 2004-07-15
• Phase I trial of anti-sense oligonucleotide vascular endothelial growth factor (VEGF-AS, Veglin) in patients with relapsed and refractory malignancies.
  Levine AM, Quinn DI, Gorospe G, Lenz HJ, Tulpule A> ;J. Clin. Oncol.. 2004-07-15
• A phase I/II trial of BBR-2778 (pixantrone), methylprednisolone, cisplatin, and cytosine arabinoside (BSHAP) in relapsed/refractory aggressive non-Hodgkin's lymphoma (...
  Camboni G, Fayad L, Tulpule A, Modiano M, Espina BM, Cabanillas F, Levine AM> ;J. Clin. Oncol.. 2004-07-15
• A phase II trial of pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone (DR-COP) in aggressive B-cell non-Hodgkin's lymphoma.
  Tulpule A, Khan AU, Mohrbacher AF, Espina BM, Buchanan L, Berman N, Gorospe G, Boswell WD, Nathwani BN, Levine AM> ;J. Clin. Oncol.. 2004-07-15
• High-dose cytosine-arabinoside and cisplatin regimens as salvage therapy for refractory or relapsed AIDS-related non-Hodgkin's lymphoma.
  Bi J, Espina BM, Tulpule A, Boswell W, Levine AM> ;J. Acquir. Immune Defic. Syndr.. 2001-12-15
• Interleukin 8 is an autocrine growth factor and a surrogate marker for Kaposi's sarcoma.
  Masood R, Cai J, Tulpule A, Zheng T, Hamilton A, Sharma S, Espina BM, Smith DL, Gill PS> ;Clin. Cancer Res.. 2001-09-01
• Clinical aspects and management of AIDS-related Kaposi's sarcoma.
  Levine AM, Tulpule A> ;Eur. J. Cancer. 2001-07-01
• Incidence and management of AIDS-related lymphoma.
  Levine AM, Seneviratne L, Tulpule A> ;Oncology (Williston Park, N.Y.). 2001-05-01
• Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin's lymphoma.
  Tulpule A, Rarick MU, Kolitz J, Bernstein J, Myers A, Buchanan LA, Espina BM, Traynor A, Letzer J, Justice GR, McDonald D, Roberts L, Boswell W, Nathwani B, Levine AM> ;Ann. Oncol.. 2001-04-01
• Evolving characteristics of AIDS-related lymphoma.
  Levine AM, Seneviratne L, Espina BM, Wohl AR, Tulpule A, Nathwani BN, Gill PS> ;Blood. 2000-12-15
• Kaposi sarcoma is a therapeutic target for vitamin D(3) receptor agonist.
  Masood R, Nagpal S, Zheng T, Cai J, Tulpule A, Smith DL, Gill PS> ;Blood. 2000-11-01
• Join now to see all

Abstracts/Posters

• Combination of Oral Nanatinostat (Nstat), a Novel Histone Deacetylase Inhibitor (HDACi), and the Oral Anti-Viral, Valganciclovir (VGCV), Is Active in Relapsed/Refracto...
  Anil Tulpule, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019